BioCentury
ARTICLE | Finance

Lots of product stories

July 3, 2000 7:00 AM UTC

While most of the Street's attention in the second quarter was lavished on genomics, momentum also was provided to the sector by a spate of product approvals in May and June.

2Q approvals...